Skip to main content
SpringerLink
Log in

Cell-mediated immunity to chemically xenogenized tumors I. Inhibition by specific antisera and H-2 association of the novel antigens

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

T cell-mediated proliferative and cytotoxic responses occur in vitro to syngeneic tumor cells antigenically altered by mutagen treatment. One such xenogenized variant of the murine L5178Y lymphoma elicits IgG antibodies reactive with determinants on variant cells that are not expressed at detectable levels on parental or normal cells of the same H-2d haplotype and are also unrelated to public specificites of H-2b or H-2k histocompatibility antigens. In the present study we investigated the effect of those antibodies on development of cell-mediated responses in vitro to the xenogenized cells used for induction of the humoral response. The proliferative reaction, generation of cytolytic activity and target cell lysis were all inhibited by the anti-xenogenized tumor immune serum, whereas the corresponding reactions to the parental cells by syngeneic or allogeneic effector lymphocytes were not. In order to investigate the possible H-2 association of T cell-mediated responses to xenogenized cells, we also examined the effect on those reactions of antibodies specific for Class I or Class II products of the H-2d complex. The results obtained suggested a role for I-Ad molecules in the T cell proliferative response to the xenogenized cells, and also indicated a preferential association of the cytotoxic response with H-2Kd determinants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aizawa S (1986) Significant frequency of cytotoxic T lymphocyte precursor cells specific for TNP-modified allogeneic cells in normal lymphocytes. Cell Immunol 103:27

    Google Scholar 

  2. Alexander P, Connell DI, Mikulska ZB (1966) Treatment of murine leukemia with spleen cells from allogeneic mice immunized against the tumor. Cancer Res 26:1508

    Google Scholar 

  3. Ben-Sasson SA, Lipscomb MF, Tucker TF, Uhr JW (1977) Specific binding of T lymphocytes to macrophages. II. Role of macrophage-associated antigen. J Immunol 119:1493

    Google Scholar 

  4. Bhattacharya D, Dorf ME, Springer TA (1982) A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol 127:2488

    Google Scholar 

  5. Bonmassar E, Bonmassar A, Vadlamudi S, Goldin A (1970) Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug. Proc Natl Acad Sci 66:1066

    Google Scholar 

  6. Bonmassar E, Bonmassar A, Vadlamudi S, Goldin A (1972) Antigenic changes of L1210 leukemia in mice treated with 5-(3,3′-dimethyl-1-triazeno) imidazole-4-carboxamide. Cancer Res 32:1446

    Google Scholar 

  7. Boon T (1983) Antigenic tumor cell variants obtained with mutagens. Adv Cancer Res 39:121

    Google Scholar 

  8. Cease KB, Buckenmeyer G, Berkower I, York-Jolley J, Berzofsky JA (1986) Immunologically relevant peptide antigen exists on the presenting cells in a manner accessible to macromolecules in solution. J Exp Med 164:1440

    Google Scholar 

  9. Clayberger C, Dekruyff RH, Aisenberg J, Cantor H (1983) Hapten-reactive inducer T cells. I. Definition of two classes of hapten-specific inducer cells. J Exp Med 157:1906

    Google Scholar 

  10. Contessa AR, Bonmassar A, Giampietri A, Circolo A, Goldin A, Fioretti MC (1981) In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3′-dimethyl-1-triazeno)imidazole-4-carboxamide. Cancer Res 41:2476

    Google Scholar 

  11. Corradin G, Engers HD (1984) Inhibition of antigen-induced T-cell clone proliferation by antigen-specific antibodies. Nature 308:547

    Google Scholar 

  12. Ellner JJ, Lipsky PE, Rosenthal AS (1977) Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes. J Immunol 118:2053

    Google Scholar 

  13. Fioretti MC, Nardelli B, Bianchi R, Nisi C, Sava G (1981) Antigenic changes of a murine lymphoma by in vivo treatment with triazene derivatives. Cancer Immunol Immunother 11:283

    Google Scholar 

  14. Fioretti MC, Romani L, Bonmassar E (1983) Antigenic changes related to drug action. In: Mirand EA, Hutchinson WB, Mihich E (eds) Biology of cancer. Alan R Liss Inc, New York, vol 1, p 435

    Google Scholar 

  15. Germain RN, Dorf ME, Benacerraf B (1975) Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor. J Exp Med 142:1023

    Google Scholar 

  16. Germain NR, Bhattacharya A, Dorf ME, Springer AT (1982) A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions. J Immunol 128:1409

    Google Scholar 

  17. Kappler JW, Skidmore B, White J, Marrack P (1981) Antigen-inducible, H-2-restricted, interleukin-2 producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 153:1198

    Google Scholar 

  18. Lemonnier F, Burakoff SJ, Mescher M, Dorf ME, Benacerraf B (1978) Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products. J Immunol 120:1717

    Google Scholar 

  19. Nicolin A, Bini A, Coronetti E, Goldin A (1974) Cellular immune response to a drug treated L5178Y lymphoma subline. Nature 251:654

    Google Scholar 

  20. Nicolin A, Spreafico F, Bonmassar E, Goldin A (1976) Antigenic changes of L5178Y lymphoma after treatment with 5-(3,3′-dimethyl-1-triazeno)imidazole-4-carboxamide in vivo. J Natl Cancer Inst 56:89

    Google Scholar 

  21. Ozato K, Mayer NM, Sachs DH (1980) Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 124:533

    Google Scholar 

  22. Ozato K, Mayer NM, Sachs DH (1982) Monoclonal antibodies to mouse major histocompatibility complex antigens. IV. A series of hybridoma clones producing anti-H-2d antibodies and an examination of expression of H-2d antigens on the surface of these cells. Transplantation 34:113

    Google Scholar 

  23. Pircher H, Zinkernagel RM, Hengartner H (1985) Inhibition of hapten-specific cytotoxic T cell recognition by monoclonal anti-hapten antibodies. Eur J Immunol 15:228

    Google Scholar 

  24. Puccetti P, Romani L, Fioretti MC (1987) Chemical xenogenization of experimental tumors. Cancer Metastasis Rev 6:93

    Google Scholar 

  25. Romani L, Fioretti MC, Bonmassar E (1979) In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3′-dimethyl-1-triazeno)imidazole-4-carboxamide. Transplantation 28:218

    Google Scholar 

  26. Romani L, Puccetti P, Fioretti MC, Mage MG (1985) Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo. Int J Cancer 36:225

    Google Scholar 

  27. Romani L, Grohmann U, Puccetti P, Nardelli B, Mage MG, Fioretti MC (1987) Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation of a highly immunogenic tumor variant (in press)

  28. Rouse BT, Roellinghoff M, Warner NL (1972) Anti-theta serum induced suppression of cellular transfer of tumor-specific immunity to a syngeneic plasma cell tumor. Nature 238:116

    Google Scholar 

  29. Sharrow SO, Ozato K, Sachs DH (1980) Phenotypic expression of I-A and I-E/C subregion determinants on murine thymocytes. J Immunol 125:2263

    Google Scholar 

  30. Shearer G, Moser M (1986) AIDS as consequence of Ia antigen recognition: a closer look. Immunology Today 7:34

    Google Scholar 

  31. Shevach EM, Paul W, Green I (1972) Histocompatibility-linked immune response gene function in guinea pigs. Specific inhibition of antigen-induced lymphocyte proliferation by alloantisera. J Exp Med 136:1207

    Google Scholar 

  32. Shevach EM, Chan C, Clement TL (1982) Nature of the antigenic complex recognized by T lymphocytes. VIII. Specific inhibition of the stimulatory capacity of antigen-pulsed hapten-modified peritoneal exudate cells by anti-hapten antibody. Eur J Immunol 12:819

    Google Scholar 

  33. Swain SL (1981) Significance of Lyt phenotypes: Lyt 2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function. Proc Natl Acad Sci 78:7101

    Google Scholar 

  34. Swain SL, Dialynas DP, Fitch Fw, English M (1984) Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex determinants. J Immunol 132:1118

    Google Scholar 

  35. Taramelli D, Romani L, Bonmassar A, Goldin A, Fioretti MC (1981) Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3′-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) in vivo. Eur J Cancer 17:441

    Google Scholar 

  36. Testorelli C, Franco P, Goldin A, Nicolin A (1978) In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas. Cancer Res 38:830

    Google Scholar 

  37. Testorelli C, Archetti YL, Aresca P, Del Vecchio L (1985) Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline. Cancer Res 45:5299

    Google Scholar 

  38. Thomas DW, Shevach EM (1978) Nature of the antigen complex recognized by T lymphocytes. VI. The effect of anti-TNP antibody on T cell responses. J Immunol 121:1145

    Google Scholar 

  39. Van Snick J, Maryanski J, Van Pel A, Parmiani G, Boon T (1982) Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens. Eur J Immunol 12:905

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, University of Perugia, Via del Giochetto, I-06100, Perugia, Italy

    Luigina Romani, Ursula Grohmann, Francesca Fazioli, Paolo Puccetti & Maria C. Fioretti

  2. Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, 20205, Bethesda, Maryland, USA

    Michael G. Mage

Authors
  1. Luigina Romani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ursula Grohmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Fazioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo Puccetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael G. Mage
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria C. Fioretti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romani, L., Grohmann, U., Fazioli, F. et al. Cell-mediated immunity to chemically xenogenized tumors I. Inhibition by specific antisera and H-2 association of the novel antigens. Cancer Immunol Immunother 26, 48–54 (1988). https://doi.org/10.1007/BF00199847

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199847

Keywords

Search

Navigation